No Detail Found!

Comparative Study of In Vitro Evaluation of Two Quinolone Derivatives by HPLC.

Author(s)
Tanweer Alam Department of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Asra Hameed Department of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Farman Ali Central Drug Laboratory, Drug Regulatory Authority of Pakistan, Karachi, Pakistan
Kashif Maseed Central Drug Laboratory, Drug Regulatory Authority of Pakistan, Karachi, Pakistan
Neelam Sharif Department of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Khan Usmanghani Department of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Ghulam Sarwer Department of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Abstract
Background: Quinolones are the antibacterial agents which vigorously inhibit the DNA synthesis. Pharmacodynamically they are DNA Gyrase inhibitor. Objective: The aim of this study is to compare two quinolone derivatives using HPLC. Result: The drug content is found to be as 96.25% in ofloxacin sample tablets and 99.64% in ciprofloxacin sample tablets when compared with standards. Conclusion: The given method has found to be speedy, exact, defined, trustworthy and minimum time taking for the concurrent process of estimating of ofloxacin as well as ciprofloxacin drugs in the system of loose drug mockups, its preparations exhausting the supreme frequently engaged C-18 column through UV indicator.
Publication Details
Page(s) 27-31
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 2, Year: 2017

Request the full text from PASTIC

Keywords
ciprofloxacin., antibacterial agents, DNA Gyrase inhibitor, ofloxacin
References
HeitmanJ.,Mandell, 2000.Bennett's principles and practice of infectious diseases,Mycopathologia 149 47 -8
HooperDC, 1993.Mechanisms of quinolone action and bacterial killing,Quinolone antimicrobial agents 53 -75
HooperDC, 1999.Mode of action of fluoroquinolones,Drugs 58 6 -10
OwensJr,RC , Ambrose,PG., 2000.Clinical use of the fluoroquinolones,Med Clin North Am 84 1447 -69
HooperDC, 2000.New uses for new and old quinolones and the challenge of resistance,Clin Infect Dis 30 243 -54
AmbrosePG,OwensJR,QuintilianiR,NightingaleCH, 1997.New generations of quinolones: with particular attention to levofloxacin,Conn Med 61 269 -72
DrewRH,GallisHA, 1988.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application,Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 8 35 -46
SamanidouVF,DemetriouCE,PapadoyannisIN, 2003.Direct determination of four fluoroquinolones, enoxacin, norfloxacin, ofloxacin, and ciprofloxacin, in pharmaceuticals and blood serum by HPLC,Anal Bioanal Chem 375 623 -9
National, 2012.Library of Medicine's Medical Subject Headings online file (MeSH,, -
SamanidouVF,DemetriouCE,PapadoyannisIN, 2003.Direct determination of four fluoroquinolones, enoxacin, norfloxacin, ofloxacin, and ciprofloxacin, in pharmaceuticals and blood serum by HPLC,Anal Bioanal Chem 375 623 -9
MaliAD,BatheR,TamboliA, 2015.Simultaneous determination of Cefiximetrihydrate and Ofloxacin in pharmaceutical dosage form by second order derivative UV spectrophotometry,International Journal of Advances in Pharmaceutical Analysis 5 -
SmithJT,Supplement, 1986.The mode of action of 4-quinolones and possible mechanisms of resistance,J Antimicrob Chemother 18 21 -9
Macías-Cortés EdelC,Llanes-GonzálezL,Aguilar-FaisalL,AsbunBojalilJ, 2015.Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, doubleblind, placebocontrolled trial,PLoS One 10 e0118440 -
OngHX,TrainiD,BebawyM,YoungaPM, 2013.Ciprofloxacin Is Actively Transported across Bronchial Lung Epithelial Cells Using a Calu-3 Air Interface Cell Model,Antimicrob Agents Chemother 57 2535 -40
LandersdorferCB,KirkpatrickCM,KinzigM,BulittaJB,HolzgrabeU,JaehdeU,ReiterA,NaberKG,RodamerM, 2010.Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid,Br J Clin Pharmacol 69 167 -78
NaveedS,NaseemY,SamieS,KhanS,SiddiquiS., 2014.Bushra and Ramzan S. Degradation Study of Five Different Brands of Ciprofloxacin Using UVVisible Spectrophotometer and Their Comparitive study,Int Res J Pharm 5 189 -90
DavisR,MarkhamA,BalfourJA. Ciprofloxacin., 1996.An updated review of its pharmacology, therapeutic efficacy and tolerability,Drugs 51 1019 -74
EronLJ,HarveyLI,HixonDL,PoretzDM, 1985.Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria,Antimicrob Agents Chemother 28 308 -10
BarkerAF,CouchL,FielSB,GotfriedMH,IlowiteJ,MeyerKC,O'donnellA,SahnSA,SmithLJ,StewartJO,AbuanT., 2000.Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis,Am J Respir Crit Care Med 162 481 -5
2009.Aerosol antibiotics in cystic fibrosis,Respiratory Care 54 658 -70
BourikasLA,KoliosG,ValatasV,NotasG,DrygiannakisI,PelagiadisI,ManousouP,KlironomosS,MouzasI,KouroumalisE., 2009.Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-b1 secretion and enhances the anti-proliferative effect of 5- fluorouracil,Br J Pharmacol 157 362 -70
0

Citations

0

Downloads

123

Views